Lecture: FDA Approval and Commercialization of a Nanomedical Device
Edward Ahn is the founder and Chief Technology Officer of Angstrom Medica, Inc. Angstrom Medica is a privately-held, early-stage, biomaterials company engaged in the development and commercialization of its proprietary nanocrystalline calcium phosphate technology - NanOss.
Guest lecture in the Nanotechnology From Lab To Market seminar series (PSE 590A).